# Altair Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/altair-therapeutics

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Website: www.altairthera.com
- Total disclosed funding: $23M
- Latest round: Series B (Feb 2, 2010)
- Investors on record: 5

## About

Altair Therapeutics is a biotechnology company focused on developing innovative therapies for various diseases. It strives to address unmet medical needs through advanced research and development.Altair Therapeutics is a biotechnology firm founded in 2007, located in San Diego, US. The company was established to create therapies targeting unmet medical needs. Altair Therapeutics has engaged in 3 funding deals and raised a total of USD 17.00 mn, with the latest funding round being Series B, amounting to USD 17.00 mn. Notable investors in this round included Domain Associates, Forward Ventures, GeneChem, and Thomas, McNerney & Partners.Altair Therapeutics specializes in developing therapeutic solutions for various health challenges, focusing on innovative treatment modalities tailored for specific diseases. The company's product portfolio aims to enhance patient outcomes through targeted therapies supported by robust research efforts.Altair Therapeutics generates revenue through its therapeutic products and potential partnerships aimed at advancing pharmaceutical research. Specific financial details regarding pricing and transaction volumes have not been disclosed but are integral to the company’s operational model.Altair Therapeutics has recently ceased operations and is no longer pursuing future growth initiatives. Therefore, there are no upcoming products or expansion plans to report.

## Funding rounds

- Series B, Feb 2, 2010, $17M — Domain Associates, Forward Ventures, Thomas, McNerney & Partners, GeneChem
- Series A, Dec 18, 2007, $6M — Domain Associates, Forward Ventures, Thomas, McNerney & Partners, GeneChem, Isis Pharmaceuticals, Inc.

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A, Series B
- Forward Ventures (https://capitalatlas.ai/funds/forward-ventures) — Series A, Series B
- Thomas, McNerney & Partners (https://capitalatlas.ai/funds/thomas-mcnerney-partners) — Series A, Series B
- GeneChem (https://capitalatlas.ai/funds/genechem) — Series A, Series B
- Isis Pharmaceuticals, Inc. — Series A